Pyridoxylamine
Product Specifications
UNSPSC Description
Pyridoxylamine is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions.
Target Antigen
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Pyridoxylamine.html
Purity
99.91
Solubility
DMSO : 16.67 mg/mL (ultrasonic)|H2O : 6.25 mg/mL (ultrasonic)
Smiles
OCC1=C(CN)C(O)=C(C)N=C1
Molecular Weight
168.19
References & Citations
[1]Stitt A, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002 Sep;51(9):2826-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B1745/Pyridoxylamine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B1745/Pyridoxylamine-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
85-87-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal FATP4/SLC27A4 Antibody (342142) [DyLight 405]](https://cdn.genprice.uk/genprice/genprice4.png)